Avid Bioservices, Inc. (CDMO)
NASDAQ: CDMO · Real-Time Price · USD
10.21
-0.15 (-1.45%)
Oct 24, 2024, 4:00 PM EDT - Market closed
Avid Bioservices Revenue
Avid Bioservices had revenue of $40.17M in the quarter ending July 31, 2024, with 6.49% growth. This brings the company's revenue in the last twelve months to $142.36M, down -5.28% year-over-year. In the fiscal year ending April 30, 2024, Avid Bioservices had annual revenue of $139.91M, down -6.27%.
Revenue (ttm)
$142.36M
Revenue Growth
-5.28%
P/S Ratio
4.61
Revenue / Employee
$383,714
Employees
371
Market Cap
651.35M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Apr 30, 2024 | 139.91M | -9.36M | -6.27% |
Apr 30, 2023 | 149.27M | 29.67M | 24.81% |
Apr 30, 2022 | 119.60M | 23.73M | 24.75% |
Apr 30, 2021 | 95.87M | 36.17M | 60.58% |
Apr 30, 2020 | 59.70M | 6.10M | 11.38% |
Apr 30, 2019 | Pro | Pro | Pro |
Apr 30, 2018 | Pro | Pro | Pro |
Apr 30, 2017 | Pro | Pro | Pro |
Apr 30, 2016 | Pro | Pro | Pro |
Apr 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Orthofix Medical | 771.65M |
Pharming Group | 277.56M |
OrthoPediatrics | 175.07M |
Y-mAbs Therapeutics | 86.55M |
CureVac | 70.57M |
IRADIMED CORPORATION | 69.48M |
CorMedix | 806.12K |
CDMO News
- 6 weeks ago - Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference - GlobeNewsWire
- 6 weeks ago - Avid Bioservices, Inc. (CDMO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024 - GlobeNewsWire
- 7 weeks ago - Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024 - GlobeNewsWire
- 4 months ago - Avid Bioservices, Inc. (CDMO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024 - GlobeNewsWire
- 4 months ago - Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024 - GlobeNewsWire
- 5 months ago - Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance - GlobeNewsWire